GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hwail Pharm Co Ltd (XKRX:061250) » Definitions » Debt-to-Equity

Hwail Pharm Co (XKRX:061250) Debt-to-Equity : 0.01 (As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Hwail Pharm Co Debt-to-Equity?

Hwail Pharm Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩2,133 Mil. Hwail Pharm Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was ₩207 Mil. Hwail Pharm Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was ₩174,454 Mil. Hwail Pharm Co's debt to equity for the quarter that ended in Dec. 2023 was 0.01.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Hwail Pharm Co's Debt-to-Equity or its related term are showing as below:

XKRX:061250' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01   Med: 0.08   Max: 0.27
Current: 0.01

During the past 13 years, the highest Debt-to-Equity Ratio of Hwail Pharm Co was 0.27. The lowest was 0.01. And the median was 0.08.

XKRX:061250's Debt-to-Equity is ranked better than
99.88% of 853 companies
in the Drug Manufacturers industry
Industry Median: 0.29 vs XKRX:061250: 0.01

Hwail Pharm Co Debt-to-Equity Historical Data

The historical data trend for Hwail Pharm Co's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hwail Pharm Co Debt-to-Equity Chart

Hwail Pharm Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.06 0.04 0.04 0.01 0.01

Hwail Pharm Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

Competitive Comparison of Hwail Pharm Co's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, Hwail Pharm Co's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hwail Pharm Co's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hwail Pharm Co's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Hwail Pharm Co's Debt-to-Equity falls into.



Hwail Pharm Co Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Hwail Pharm Co's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Hwail Pharm Co's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hwail Pharm Co  (XKRX:061250) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Hwail Pharm Co Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Hwail Pharm Co's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Hwail Pharm Co (XKRX:061250) Business Description

Traded in Other Exchanges
N/A
Address
904-7, Sangsin-Ri, Hyangnam-Eup, Hwaseong, Gyeonggi, KOR, 445-746
Hwail Pharm Co Ltd is engaged in manufacturing and distribution of raw materials used in pharmaceutical production. Its products include antitussive expectorants, spasmolytic, stomach function modifier, anti-inflammatory, and others.

Hwail Pharm Co (XKRX:061250) Headlines

No Headlines